Screener
Arcutis Biotherapeutics, Inc. ARQT Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other revenue | — | — | — | 2,000 |
| Total revenues | 129,861 | 81,504 | 235,259 | 147,350 |
| Operating expenses: | ||||
| Cost of sales | 10,939 | 7,492 | 20,723 | 16,322 |
| Research and development | 20,355 | 19,453 | 50,982 | 36,996 |
| Selling, general and administrative | 82,138 | 69,170 | 156,214 | 133,172 |
| Total operating expenses | 113,432 | 96,115 | 227,919 | 186,490 |
| Income (loss) from operations | 16,429 | (14,611) | 7,340 | (39,140) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s total cost of revenue?
- Arcutis Biotherapeutics, Inc. (ARQT) reported total cost of revenue of $10.94M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s total cost of revenue changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s total cost of revenue increased by 46.0% year-over-year, from $7.49M to $10.94M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Arcutis Biotherapeutics, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude